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Habitual consumption of poor quality diets is linked directly to risk factors for many non-
communicable disease. This has resulted in the vast majority of countries globally and the 
World Health Organaisation developing policies for healthy eating to reduce the prevalence of 
non communicable disease in the population. However, there is mounting evidence of 
variability in individual metabolic responses to any dietary intervention. We have developed a 
method for applying a pipeline for understanding inter-individual differences in response to 
diet, based on coupling data from highly-controlled dietary studies with deep metabolic 
phenotyping. In this feasibility study, we create an individual Dietary Metabotype Score (DMS) 
that embodies inter-individual variability in dietary response and captures consequent dynamic 
changes in concentrations of urinary metabolites. We find an inverse relationship between the 
DMS and blood glucose concentration. There is also a relationship between the DMS and 
urinary metabolic energy loss. Furthermore we employ a metabolic entropy approach to 
visualize individual and collective responses to dietary. Potentially, the DMS offers a method 
to target and to enhance dietary response at an individual level therefore reducing burden of 
non communicable diseases at a population level.  
 





One in five deaths are directly attributable to poor diet1,2. Evidence from large interventions 
demonstrates that risk of type 2 diabetes and coronary artery disease is reduced by a healthier 
lifestyle, which includes consumption of a high-quality diet, and population based national and 
international dietary guidelines for non-communicable disease (NCD) prevention have been 
developed. However, recent evidence demonstrates that individuals respond differently to the 
same diet in terms of impact on metabolism and clinical outcomes3-14. Exploitation of this 
heterogeneity in dietary response has given rise to the concept of precision nutrition14,15, the 
ambition of which is to optimise individual responses to dietary intervention on the basis of 
understanding the determinants of these individual responses to nutritional intakes. Current 
tools for measuring individual dietary intake, such as food frequency questionnaires, dietary 
recalls or diet diaries are subject to significant reporting bias and misreporting16, and are 
inadequate for assessing individual compliance with dietary recommendations. In addition, 
recent evidence indicates that matching diet to genotype produces no further benefit in dietary 
response over personalised dietary advice17. This highlights the need for new technical 
approaches for understanding the individual’s metabolic response to a dietary intervention  
Metabolic phenotypes (metabotypes) are the products of interactions between an 
individual’s genotype and multiple environmental factors including diet, other lifestyle factors 
and the gut microbiome3,6,18-20. In this feasibility study, we develop and apply precision nutrition 
tools for mapping dietary response at the individual level. Our aim is to provide a measure of 
metabolic variability and identify inter-individual differences in response to diet in order to 
individualise healthy eating advice which will lead to a reduction in the risk of NCD. 
We employed a previously reported methodology21 to capture a systemic overview of 
metabolic response to each of four specific standardized diets using metabolic phenotyping of 
urine samples (Fig. 1). We developed four experimental dietary interventions with stepwise 
degrees of concordance to the World Health Organisation’s (WHO) healthy eating guidelines22 
(increase fruits, vegetables, wholegrains and dietary fibre and decrease fats, sugars, and salt); 
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Diet 1 is the most concordant, Diet 4 the least concordant, and there are two intermediate 
diets (Diets 2 and 3). Information on meals that were provided to participants in each diet are 
detailed in Extended Data Table 1, including the macronutrient content. Healthy participants 
(n=19) attended a clinical research unit on four separate occasions and followed these diets 
in random order. Each intervention period lasted for 3-days during which participants were 
observed continually to ensure adherence to the diet. Figure 1 is a schematic of the study 
design. In the following series of experiments we use this analytical framework to explore the 
role of individual metabolic profiles and the physiological significance of these responses. 
 
Results 
Understanding the dietary metabolite phenotype 
The metabolic phenotypic response of participants to each diet, characterized by 1H-
NMR spectroscopy and Principal Component Analysis of 24hr urine samples (pooled from 
each void throughout the 24hr period) were found to cluster according to diet (Fig. 2A, with 
representative spectra shown in Fig. 1 and Supplementary Fig. 1). This indicates that 
participants’ urinary metabolic phenotypes were modulated systematically by changing diet. It 
is of interest that the urinary metabolic phenotype of participants after following Diet 1 (most 
concordant with WHO guidelines) are consistent with phenotypes previously associated with 
lean individuals, for example higher levels of hippurate and vitamin-related compounds such 
as niacin; whereas the Diet 4 metabolic phenotype reflects that reported for obese individuals 
(for example higher levels of glucose, carnitines, fatty acids, etc.)19 (see Supplementary 
Table 1). Despite the rigor of the controlled environment and participants’ adherence over 
each 3-day intervention period, there was considerable inter-individual variability in the urinary 
metabolic phenotype and the excretion of individual metabolites in response to each diet, as 
exemplified by Fig. 2B-D (B, hippurate associated with fruit and vegetable intake23; C, 3-
methylhistidine associated with (lean) meats24, for example poultry; D, carnitine associated 
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with red meat7), and Supplementary Fig. 2 (showing an extended panel of twenty 
metabolites). Even urinary levels of metabolites directly derived from intake of specific foods 
and excreted largely without further metabolism (e.g. prolinebetaine from citrus fruit) show 
high inter-individual variability. These inter-individual differences were not explained by sex, 
age, body mass index (BMI) or health history of participants. 
 
Development of a Dietary Metabotype Score 
Urinary metabolite profiles reflect the phenotype of individuals and are particularly responsive 
to dietary interventions12,21. We developed the Dietary Metabotype Score (DMS), based on a 
Monte Carlo Cross-Validation Partial Least Squares (MCCV-PLS) model (see Methods, 
Supplementary Fig. 3) to quantify individual variation in urinary metabolic phenotype in 
response to a test diet.Thus the DMS for any individual at any given time quantifies the 
similarity of that individual’s urinary metabolite profile to the metabolic phenotypes of the 
remaining volunteers of the two extreme diets21 (Diets 1 and 4) with +1 reflecting a score that 
would represent full adherence to Diet 1 (most concordant with WHO guidelines) and -1 
reflecting a spectral profile obtained after full adherence to Diet 4 (least concordant). Since 
the DMS is based on the whole spectral profile (16,000 variables, which includes metabolites 
we have identified here, as well as (presently) unknown signals that are associated with the 
different diets Fig. 3), changes in both the number and the intensity of signals (relating to 
diversity and concentration of metabolites) will contribute to the end score, thus a high DMS 
will reflect stronger changes in number and/or concentration of metabolites.  
The predicted DMS of participants consuming diets more adherent to WHO 
guidelines22 (Diet 1) (Fig. 4A, Supplementary Fig. 4) was higher than the DMS calculated 
when participants were following Diet 4 (least concordance with guidelines). The DMS is 
presented in rank order (colourbar to the right of Fig. 4A indicates the rank of each participant) 
to visualize the variability in response to Diet 1. For instance, the participants with the strongest 
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metabolic response to Diet 1 will be at the top of the ranking order (green region of the 
colourbar) while the one with the least pronounced metabolic response to Diet 1 will be at the 
bottom of the ranking order (red region of the colourbar). As expected, each participant shows 
a gradual rise in DMS from Diet 4 to Diet 1; the more concordant the diet is with WHO 
guidelines, the higher the DMS. However inter-individual variability in response to each of the 
four diets is observed. In addition, data from days 1 and 2 can still be predictive of the diet 
intervention, however they could also reflect markers related to their habitual diet at home. 
Therefore we applied the same framework on the day 2 samples and found similar 
classification accuracies as for the day 3 model, but with a lower Q2Y value (Q2Y=0.82 (day 2), 
Q2Y=0.85 (day 3 model)). The important variables are very similar between these two models 
(Fig. 3 and Supplementary Fig. 5, Supplementary Table 1B). Combining data from days 1-
3 does give a good predictive model, however there is a reduced significance of multiple 
metabolites (Supplementary Fig. 6, Supplementary Table 1B), which could relate to 
including data of short-term exposure (day 1 samples). 
The variability in the DMS between participants for different diets was not attributed to 
age, BMI, fat percentage of total body weight (Supplementary Fig. 7) or sex (Supplementary 
Fig. 8). However some metabolites that are excreted in different amounts in women and men 
(Fig. 2 and Supplementary Fig. 2), are consistent with previous literature25. Comparisons of 
our model (Fig. 3) with sex-specific models (Supplementary Fig. 9 and 10) reveal that with 
the exception of creatine in the men-specific model, all metabolites from the DMS model are 
significant in the models built from male participants and in the models built from female 
participants (Supplementary Table 1B). Also they have the same sign of association as the 
combined model. The sex-specific models have a smaller number of samples as part of the 
training set, and larger number of part of the test data, than the DMS model. Therefore 
comparison of our DMS model with a model where the training-to-test set ratio is similar to 
that of sex-specific models. The splitting (50:50 opposed to 80:20) does not impact on the 
associated metabolites (Supplementary Fig. 11). Additionally, we calculate two regression 
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models with the DASH score calculated for the 4 diets and the adherence to WHO guidelines 
(Supplementary Fig. 12 and 13) and while these models are predictive with multiple 
coherence of differential metabolites between WHO concordant and discordant diets, not all 
metabolites previously found in the DMS model are associated with these two subsequent 
models. Both of these regression models are relatively linear (Supplementary Fig. 12A and 
13A) however not all dietary components (foods and macronutrients, Extended Data Table 
1) are linear with the diets, such as protein, and this is reflected in the urea that does not 
significantly contribute to the DMS model but significantly contributes to the DASH score 
regression model and the WHO alignment regression model.  
  To validate these findings, we used a new metabolomic discovery study with a less 
stringent control. Ten volunteers were fed a standardized diet that reflects diet 1 for four days 
with all their food being provided for breakfast, lunch and two snacks. The evening meal was 
provided to the volunteer to consume at home (see Methods for details). We found similar 
results to the initial study with a large between individual variability, despite the dietary control. 
As the diet was the same over four days there was no linear change over time 
(Supplementary Fig. 14A). Next, we combined all the data for each person and represent 
this in a violin plot ordered based on the median DMS (Supplementary Fig. 14B), which 
shows the distribution of the DMS for each participant combining the four days. This 
demonstrates some participants that have very similar DMS, whereas others differ significantly 
highlighting the occurrence of inter-individual variability. 
Calculation of the DMS in this cohort revealed that dietary habits in the home 
environment are highly variable between individuals as well as within individuals (Extended 
Data Fig. 1). For example, participant 16 shows a high DMS (aligning with WHO guidelines) 
before starting all diets. While participant 10 shows higher DMS before the admission to Diet 
1 and 4 and lower DMS before starting Diet 2 and 3. Since participants’ DMS at baseline does 
not determine the DMS after the test diets (Fig. 4B-C), the order of DMS prior to Diet 1 does 
not relate to the DMS ranking order after Diet 1 (Fig. 4B) and the order before Diet 4 does not 
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relate to the DMS ranking after Diet 4 (Fig. 4C). Moreover, Fig. 4B and C show a clear 
decrease in the variability of participants’ DMS after exposure to the controlled diets for three 
days. It appears that in general the volunteers’ DMS score prior to the diet fell between the 
most and least concordant diets with 12/19 participants increasing the score in response to 
Diet 1 (most concordant with WHO guidelines) and 13/19 participants decreasing their score 
to Diet 4 (least concordant).  
 
Exploring the DMS and the impact on physiology 
Individual DMS values were associated with health-related biomarkers. For example, there 
was an inverse association between DMS rank and blood glucose (Supplementary Table 2) 
for the total post-prandial glucose across all four diets (Fig. 4D, P-value=3.20×10-3), and within 
each diet for both post-prandial (Fig. 4D, P-value=2.59×10-2 to 3.42×10-3) and fasting glucose 
(Supplementary Fig. 15, P-value=2.17×10-2 to 3.30×10-3). Adjustment for age, sex and BMI 
did not change the magnitude of these correlations appreciably. We validated these 
observations in a cohort of healthy middle-age overweight individuals (n=65, female=31; 
age=59±4, BMI=29.0±2.9kg/m2) (see Methods). We demonstrated that the DMS was 
inversely related to the area under the glucose and insulin curves following mixed meal 
tolerance tests (P-value=1.65×10-2 and P-value=4.39×10-2, respectively), plus fasting HDL-
cholesterol (P-value=1.33×10-2), the ratio of total to HDL-cholesterol (P-value=2.28×10-2) and 
blood triglycerides (P-value=4.39×10-2) (Supplementary Fig. 16). However the relationship 
of the DMS to fasting blood glucose was not found to be significant (P-value=1.88×10-1). The 
validation cohort supports the observed association of DMS with a number of important health 
related markers. 
We measured the energy content of the urine directly using Bomb Calorimetry (see 
Methods). The range of urine energy values was similar to those previously reported in 
healthy humans 26 (Fig. 4E). Evidence of inter-individual variability in the 24hr urinary energy 
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loss, via excretion, in relation to the DMS is shown in Fig. 4E (and Supplementary Fig. 17). 
The energy loss was directly related to the ranking of the DMS for Diet 1 (ρ=0.93, P-
value=2.14×10-6) and inversely related to the DMS ranking for Diet 4 (ρ=-0.97, P-
value=2.62×10-8). There were no correlations between urinary energy content and either 
urinary urea or urinary glucose, or between blood glucose measurements and urinary glucose 
(Supplementary Fig. 18). 
The urinary energy content was significantly related to higher excretion of multiple 
metabolites (Supplementary Table 3), including metabolites of microbial origin (hippurate, 
phenylacetylglutamine, formate, 4-cresylsulphate, 4-cresylglucuronide and 2-
hydroxyisobutyrate). The formation of microbial metabolites is endothermic, requiring energy, 
but also represents a potentially significant energy loss to the host via Phase II metabolic 
conversions of selected carbon sources, which renders the carbon skeleton unavailable for 
energy metabolism by the host. For example, the conjugation of phenylacetate and glutamine 
to form phenylacetylglutamine results in a loss of energy by decreasing the accessability of 
glutamine for energy metabolism. However, microbial metabolites typically also: for example, 
hippurate is higher in urine samples from Diet 1 due to increased intake of fruits and 
vegetables, whereas phenylacetylglutamine is higher in urine after Diet 4 and related to the 
increased consumption of animal protein in this diet (Supplementary Table 1A). 
While the DMS ranking order and energy loss are related and share common 
metabolites (hippurate, phenylacetylglutamine, as well as non-microbial metabolites), there 
are additional microbial metabolites associated only with urinary energy content (formate, 4-
cresylsulphate, 4-cresylglucuronide and 2-hydroxyisobutyrate) that reflect the influence of the 
gut microbiota on urinary energy loss. 
 
Impact of dietary intervention on individual metabolic network maps 
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To understand the wider impact of the dietary intervention on human metabolism, we 
generated a urinary metabolic reaction networks map (Fig. 5A) using a previously described 
methodology to visualise reactions between metabolites in relation to associated metabolic 
pathways27. We constructed this metabolic network map using the set of 32 metabolites as 
anchor points, where the excretion was significantly different after following Diet 1 (most 
concordant with WHO dietary guidelines) and Diet 4 (least concordant) for all 19 healthy 
participants21. The connectivity of these 32 metabolites (i.e. the minimum number of 
biochemical reactions required to connect all 32 metabolites) takes place through 234 
metabolites (white nodes) as part of the human supra-organism metabolic reaction network27. 
Compounds associated with lipid, glucose and energy metabolism explain a greater 
proportion of the metabolic phenotype in Diet 4 compared to Diet 1. This observation aligns 
with the blood chemistry measurements which, despite the short intervention period, are 
significantly different between Diets 1 and 4 for average post-prandial glucose (P-
value=0.036) and show a trend toward a lower fasting total cholesterol (P-value=0.056) and 
triglycerides (P-value=0.058) (Supplementary Table 2). 
All 33 metabolites show inter-individual variation in excretion between participants 
(Fig. 2B-D, Supplementary Fig. 2), suggesting homeostatic mechanisms are, to an extent, 
specific for each person. In order to quantify this type of metabolic variation, we calculate a 
measure of system disorder (metabolic entropy) based on the fold-change in excretion of each 
of the 33 urinary metabolites to measure the robustness of a person’s metabolism under 
dietary challenge of Diets 1 and 4 (see Methods). This entropy measure was used to map the 
metabolic differences (in response to Diets 1 and 4 for each participant) onto the skeleton 
outline of the urinary metabolic reaction networks map, as exemplified in Fig. 5B-C for 
participants 6 and 16 (highest and lowest metabolic entropy, respectively) and Extended Data 
Figs. 2 and 3 (all other participants). In each of these figures the size of the metabolite node 
is proportional to the metabolite fold-change between Diets 1 and 4, and the paths connecting 
two metabolites are weighted by the average fold-change of the two metabolites in the 
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respective diets (see Methods) to visualize the different utilization of pathways at the 
individual level. The higher the associated entropy of a pathway, the larger the potential energy 
loss from that pathway to the urine. 
Each individual metabolic network highlights the expression of the participant’s 
metabolic phenotype and allows us to further investigate participants’ variability in response 
to each reference diet based on the entropies associated with specific pathways. For instance, 
participant 6 (highest metabolic entropy, second highest DMS, second highest urinary energy 
excretion) exhibits higher expression of most of the pathways associated with the 32 
metabolites in comparison with the other participants (Fig. 5B, and Extended Data Figs. 2 
and 3). Whereas the metabolic network for participant 16 (lowest metabolic entropy, lowest 
DMS, lowest urinary energy excretion) indicates that specific compartments, mostly related to 
TCA anaplerotic and mitochondrial CoA metabolism, may contribute more to their urinary 
residual energy in this participant than other pathways such as histidine and beta-alanine 
metabolism (Fig. 5C). 
 
Discussion 
We have used individuals’ urinary metabolic phenotypes to demonstrate that even in a highly 
controlled environment individuals’ metabolic reponses to diet differs. Our data suggest that 
everyone has a unique dietary metabotype that relates to the individuals’ physiological 
homeostasis, as demonstrated by glycaemic control. Our results support previous studies3,4 
in highlighting the need to understand individual response to lifestyle to enhance response to 
dietary intervention. 
In this feasibility study we have found that among a ‘healthy’ group of subjects, the 
participants who have a higher loss of energy in the urine (i.e. those that also are at the top of 
the dietary metabotype score ranking) demonstrate greater urinary excretion of microbial 
metabolites. The energy content of urine in humans has so far been little studied but, as far 
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back as 1901, Rubner et al. observed that in addition to urea there were calorific substances 
in urine28. Here we describe a portfolio of microbial gut derived metabolites that could 
contribute to energy content of urine and which account for variation in urinary energy values 
between individuals. We did not collect feaces for microbiota analysis during this study as gut 
transit in humans is relatively long and variable29 and the length of dietary intervention in this 
study was three days, so a feaces collected on day three may not represent the microbial 
change induces by the diet30. In humans, energy loss in the excreta is around 175kcal/day 
(0.73MJ) in faeces and 78kcal/day (0.33MJ) in urine26,31. This may make urine energy 
excretion seem relatively unimportant. However, small changes in energy balance can make 
significant impact over time. For example, the average weight gain in adults per year is 500g 
which is approximately 3500kcal; this is an intake excess of less than 10kcal/day. The 
difference in urinary energy excretion between the lowest and highest energy excretor in Diet 
1 reflects an increase of 4% in energy loss in the urine, which is equal to 4kcal/day and a total 
of 1500kcal per year which will account for 215g of fat difference per year between these two 
individuals. Thus, this apparently small change over time becomes clinically important. In 
urine, we observe conjugated microbial products that make the carbon skeleton of the 
molecule unavailable to the host. Whether it is possible to manipulate this energy loss via gut 
microbial modulation as a way of preventing weight gain remains unknown at the present time. 
Based on the observed inter-individual differences in urinary energy loss, we explored 
the variability in response to the same diet at a metabolic pathway level to gain better insight 
into the intricate regulatory networks shaping a given phenotypic response. By using individual 
urinary metabolic reaction network maps, we showed substantial variation between the 
composite metabolic outputs of individuals that shared similar DMS. The mechanism driving 
these observations is currently unknown, but individual genotype and/or gut microbial 
composition are likely to contribute. A limitation of these maps is that they are built using 
urinary metabolites alone. Nevertheless, before a metabolite ends up in the urine it is generally 
in the plasma/circulatory system (or of renal origin) and thus metabolites in 24hr urine samples 
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are a time-averaged representation of the homeostatic signatures of multiple organ and 
cellular systems in the body. 
In summary, our feasibility study demonstrates that there are inter-individual 
differences in response to the same diet, even when the environment is controlled. We have 
developed a modelling framework that could be used to monitor individual response to diet 
and which provides a mechanism for enhancing dietary advice with the potential to inform 
decision-making strategies for the prevention, risk reduction and clinical management of non-
communicable diseases for precision medicine. 
 
Materials and Methods 
Study protocol, ethics and consent – The study was approved by the London–Brent 
Research Ethics Committee and carried out in accordance with the Declaration of Helsinki 
(13/LO/0078). The study protocol is available from reference21. All participants provided written 
informed consent. An external cohort (NutriTech32) was used to validate associations with 
health-related markers (London Brent Ethics Committee reference number: 12/LO/0139). This 
dataset contained 65 participants (31 female), with a mean BMI of 29.0±2.9 kg/m2 at baseline, 
for which urine samples were available from baseline measurements prior to starting the 
clinical trial (NCT01684917). We used our metabolite discovery study which uses a semi 
controlled 4 day feeding study. Ethical approval for the this study is subsidiary to the main 
study “Dietary biomarker discovery using metabonomics”. The study was approved by the 
London–Brent Research Ethics Committee and done in accordance with the Declaration of 
Helsinki (13/LO/0078). 
 
Validation study design: The methodology used was a four day controlled diet coupled to a 
food challenge study. The aim of the challenge study is to identify and quantify potential 
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candidate dietary biomarkers. The study we used to report the stability of the metabolite profile 
aimed to develop a biomarker for egg intake. 10 healthy participants were recruited (4 males 
and 6 females, aged 23 to 34, BMI range from 18 to 27, mean BMI 22±3kg/m2). All participants 
provided written informed consent prior to the beginning of the study. Breakfast (8am) and 
lunch (1pm) were provided to the participants (details of the food consumed are given in 
Supplementary Table 4. The participancts were given an evening meal consisting of rice, 
carrots, lettuce, salt, and olive oil), plus the test food (eggs) in increasing doses over the 4 
days (day 1 = 0 eggs, day 2 = 1 egg, day 3 = 2 eggs, day 4 = 4 eggs). The nutrient profile was 
64% energy from carbohydrate, 26% fat and 10% protein which would be aligned to Diet 1. 
After consuming the meal, participants collected their 12-hour overnight urine excretion from 
8pm-8am. Urine samples were collected into sterilised single containers overnight, and then 
stored in sterilised Eppendorf’s at -80ºC. 
 
NMR spectroscopy and data pre-processing – Urine samples were prepared with 
a pH 7.4 phosphate buffer for ¹H-NMR spectroscopy as described previously21 and analysed 
at 300K on a 600 MHz spectrometer (Bruker BioSpin, Karlsruhe, Germany). The following 
standard one-dimensional pulse sequence with saturation of the water resonance was used: 
RD – gz,1 – 90° – t – 90° – tm – gz,2 – 90° – ACQ, where RD is the relaxation delay, t is a 
short delay typically of about 4μs, 90° represents a 90° radio-frequency pulse, tm is the mixing 
time (10ms), gz,1 and gz,2 are magnetic field z-gradients both applied for 1ms, and ACQ is 
the data acquisition period (2.7s). The receiver gain was set to 90.5 for all experiments and 
water suppression was achieved through continuous wave irradiation at the water resonance 
frequency using 25Hz radio-frequency pulse strength during the RD and tm. Each urine 
spectrum was acquired using 4 dummy scans, 32 scans, 64K time domain points and with a 
spectral window set to 20 ppm for urine. Prior to Fourier transformation, the free induction 
decays were multiplied by an exponential function corresponding to a line broadening of 0.3 
Hz. 1H NMR spectra were manually phased and digitized over the range δ -0.5 to 9.5 and 
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imported into MATLAB (2014a, MathWorks, Natick, U.S.A.). Each spectrum was baseline 
corrected using in-house software. Spectra were subsequently referenced to the internal 
chemical shift reference (trimethylsilyl-[2,2,3,3,-2H4]-propionate, TSP) at δ 0.0. Spectral 
regions containing the signals from the internal standard (δ -0.5 to 0.5) and water (δ 4.5 to 
5.5) were excluded prior to probabilitistic quotient normalisation. Urine samples from both the 
NutriTech and metabolite discovery study were analysed using the same acquisition 
parameters as above, and normalized using the same reference for the main study data. Each 
spectrum consisted of 16,000 variables after pre-processing. Subset optimization by reference 
matching33 (STORM) was used to identify metabolites using the correlation structure of 1H 
NMR data. Localized clustering of small spectral regions was used for selecting appropriate 
reference spectra. Additionally, a Bruker compound library, internal databases, and extensive 
2D NMR identification strategies34 were used for identification of molecular species. 
 
Calorimetric determination of urine – 24hr urine samples collected on day-3 from 19 
participants following diets 1 and 4 were analysed using a C1-Bomb Calorimeter (IKA Werke 
GmbH & Co, Staufen, Germany). The Bomb Calorimeter was calibrated with 0.5g benzoic 
acid with calorific value of 26,461 Joules/g (J/g). 3 ml of each 24-hour urine sample was dried 
using nitrogen gas and weighed on an analytical scale before being placed in a glass crucible. 
Three drops of a paraffin oil ignition, which has a calorific value of 46,634 J/g, were weighed 
on an analytical balance and spiked on the dried urine sample. The amount of the external 
energy from the paraffin oil was inserted in the calculation software of the equipment as well 
as the net weight of the sample to be quantified. These data were taken into account by the 
software to determine the calorific value of urine in J/g. For 11 samples (see Supplementary 





Measurement of glucose serum levels – Serum glucose was measured from blood collected 
into serum-separating tubes and assayed using the Infinity Hexokinase Reagent (Thermo 
Scientific, USA) measured on a Spectramax I3X plate reader (Molecular Devices, U.S.A.). 
Variability in the glucose incremental AUC refers to the area included between the baseline 
(fasting blood glucose) and the incremental serum glucose concentrations measured at each 
time point (2 hours after breakfast, 2 hours after lunch and 2 hours after dinner). The area 
under each incremental glucose curve was calculated using the trapezoid rule. 
 
Statistical analysis (Dietary Metabotype Score) – Data from the 24-hour urine samples 
collected on day 3 from 19 participants following Diets 1 and 4 were used to construct a Monte 
Carlo Cross-Validated Partial Least Squares (MCCV-PLS) model35. Samples from day 3 were 
used as we previously observed that there appears to be dietary homeostasis after 3 days of 
following the same diet21,36. The paired data were mean-centered within each person to 
account for the repeated measures design. The model data (n=19×2) were randomly divided 
into a training and a test set for each of the 1,000 Monte Carlo iterations. The test set contained 
all data (both Diet 1 and Diet 4 samples) from 3-4 individuals at each iteration (mean 3.8, 
median 4), equivalent to 20% of the data. The training data were used to construct a PLS 
model and optimize the number of components using an internal double cross-validation (CV) 
loop. The ratio between Q2Y (goodness-of-prediction) and R2Y (goodness-of-fit) of the training 
data was used to select the optimal number of components from the calculated models. The 
maximum number of components that the model is optimized for is set to the number of 
training samples (in the double CV loop) minus 1 (in practice this is never more than 11, and 
a histogram of the optimal number of components across all models is shown in 
Supplementary Fig. 3, with a median of 2 components). The training data were scaled to 
unit-variance and the test data were scaled using the standard deviation from the training data 
(centering was done within person, see below). This framework ensures that the test data are 
never used in modelling or determining scaling parameters and can thus be predicted without 
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any introduced bias or over-fitting35. The final model contains 1,000 individual models that are 
calculated using a training set with different individuals each time. The entire data for each 
individual is left out of the training set on multiple occasions in the MCCV: i.e. it is then part of 
the test set for that specific iteration. The average of the predictions from all models where the 
data from an individual was in the test set was taken to predict the Dietary Metabotype Score 
(DMS).  
The data from 24hr urine samples from Diets 1 and 4 taken on days 1 and 2 are not 
used in the model and are used as a separate validation set. These data are first centered 
within-person using the mean from the day 3 samples to account for the paired design. These 
data are then predicted using the MCCV model and applying scaling parameters (standard 
deviation) from the training data (see above) for each of the 1,000 individual models. The DMS 
is defined as the average of the predictions where the data from an individual was used in the 
test set in the model. Samples from all 3 days for Diets 2 and 3 are predicted the same way 
as the day 1 and 2 samples from Diets 1 and 4. 
For the training set the DMS for Diets 1 and 4 correspond to +1 and -1. The DMS for 
test data is expected to be around +1 for Diet 1 and around -1 for Diet 4 and in between +1 
and -1 for Diets 2 and 3. However, the DMS for test data can go beyond the range of +1 and 
-1 due to individual variability and to account for data that is more/less concordant with WHO 
guidelines than Diet 1/Diet 4. In general, any positive score is more consistent with Diet 1, 
whereas a negative score is more reflective of Diet 4. 
In order to assess the robustness of the DMS model we also investigated models using 
day 2 samples as the model set and all samples from days 1-3 as model set, these analyses 
used the same framework as described above (with the same splitting ratio into training and 
test sets and within-person centering (explained below)). In addition, we calculated sex-
specific models where the samples from men are used as training data, and the women are 
the test data, and vice versa. In this case the splitting between training and test is 50:50 
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(opposed to 80:20 in the DMS model) and therefore we also compared these with a model 
that randomly splits the data 50:50 (irrespective of sex). Lastly, we used the DASH score of 
the diets and the adherence of each diet to WHO guidelines in two regression models (using 
day 3 samples) to use the urinary metabolites to predict these. The framework used for these 
analyses is the same as for the DMS. 
The repeated measures design of the data is accounted for in the centering of the data. 
Any data used in the modelling is centered within-person: all data for each person (regardless 
of whether they are in a training or test set) is centered individually. This allows for the model 
to focus on changes in metabolite excretions relative to each individual’s metabolic phenotype. 
The scaling of variables (unit-variance) was applied using all data after the centering step. The 
standard deviation from the training data is used and applied on the test and validation data 
sets – so there is never any information from the test and validation sets in the calculation of 
the model (for choosing the optimal number of components we used a further splitting of the 
training data in each iteration to inform on the number of components). 
The samples from both the NutriTech and metabolite discovery study were centered 
based on the average of the main study data, and scaled using the parameters from each 
individual model (training data). As these samples are from independent individuals, all 1,000 
models from the MCCV are used to calculate the DMS. 
 
Statistical analysis (urinary energy) – The 24hr urinary 1H NMR spectroscopic profiles of 
all participants were regressed against the calorific value using standard linear regression, 
adjusted for multiple testing using the Storey-Tibshirani False Discovery Rate37 (FDR). 
(Partial) Spearman correlation was used to compare the DMS ranking with other study 




Bioinformatics analysis (MetaboNetworks maps) – A urinary metabolic reaction network 
map was constructed using the MetaboNetworks software27 by connecting the 33 metabolites 
that were identified from the MCCV PLS model using the KEGG database of biochemical 
reactions that occur in the human supra-organism. The bacteria that make up 99% of the 
colonies commonly found in the human gut38,39 were included in the MetaboNetworks 
database, since many of the urinary metabolites are known to derive fully or partially from the 
gut bacteria. In the database any reaction that can occur either spontaneously, due to an 
enzyme linked to a Homo sapiens gene, or due to an enzyme linked to a microbial gene (3,282 
species were included from the phyla actinobacteria, bacteroidetes, cyanobacteria, firmicutes, 
fusobacteria, proteobacteria, tenericutes and verrucobacteria) was included.  
 
Metabolic Entropy calculations – The entropy was calculated using the metabolite excretion 
data from both Diet 1 and Diet 4 and is a single value for each person that is related to the 
within-individual differences associated with Diets 1 and 4. Metabolites found in higher 
concentrations in urine of participants after following Diet 1 (‘M1’), and those metabolites found 
in higher concentrations in urine after Diet 4 (‘M4’), are considered to be in the perturbed state. 
The corresponding baseline levels were the concentration of M1 metabolites in Diet 4 (‘B4’) 
and M4 metabolites in Diet 1 (‘B1’). For simplicity, two data matrices of fitted metabolite data 
are used, ‘M’ for metabolites in the perturbed state (n=19 (participants) by p=33 (metabolites), 
both M1 and M4) and ‘B’ for metabolites in the baseline state (dimension 19×33, both B4 and 







each metabolite per participant based on a fold-change in excretion between Diet 1 and 4 for 
each participant normalized by the log-normalized standard deviation (𝑤𝑗 = std(log(𝐵𝑗))) of 
the baseline levels – analogous to similar methods40. However, metabolites that relate directly 
to specific foods (such as tartrate41 and N-acetyl-S-(1Z)-propenyl-cysteine-sulfoxide34) will 
exhibit a large fold-change, thus large entropy, and dominate the total entropy over changes 
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in endogenous metabolites. In order to make the comparison between metabolites more 




) before calculating the metabolic 
entropy (𝑆) per participant. 𝑆 is calculated as the sum across the columns of 𝑠 (𝑆𝑖 = ∑ 𝑠𝑖𝑗
∗𝑝
𝑗=1 ). 
As we normalized the fold changes, and then auto-scaled the data the entropy is expressed 
in arbitrary units. 
Using the MetaboNetworks urinary metabolic reaction network as a layout, individual 
metabolic networks were constructed for each individual where the size of each node 
(metabolite) is proportional to the metabolite entropy (𝑠𝑖𝑗
∗ ). Next, for each pair of metabolites 
the shortest path (number of reactions) was extracted from the network and each edge 
(reaction) in the path was weighted by the average entropy of the two metabolites. For 
individuals where pairs of excreted metabolites are correlated, the reactions (and associated 
pathways) that connect those metabolites will have higher weights than those from pairs of 
metabolites that are excreted in lower amounts and/or are uncorrelated. This highlights the 
pathways that are associated with the individual’s metabolic profile. 
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Fig. 1 | Schematic representation of methodology. Four diets with different levels of concordance with WHO 
healthy eating guidelines were provided to each of 19 healthy participants in a random order. The macronutrient 
content displayed in the pie charts shows the proportions of energy from fats (red sli ce), carbohydrates (orange 
slice) and proteins (green slice) for the most (Diet 1) to the least (Diet 4) concordant diets. Fibre (blue bar), sugar 
(pink bar) and the Dietary Approaches to Stop Hypertension (DASH) score (green bar, the higher the better) for 
each of the four diets are shown in the adjacent histograms. 24hr Urine samples were collected daily over each 3 -
day period and analysed using proton Nuclear Magnetic Resonance (1H-NMR) spectroscopy to generate one 
metabolite profile per sample. The urinary metabolite profiles from the most and least concordant diets (Diets 1 
and 4) were used to create a mathematical model to calculate a score that summarises the response of an 
individual to diet (Dietary Metabotype Score; DMS). Finally, we investigated relationships between the DMS and 
urinary energy loss, metabolic networks and blood glucose concentration.  
 
Fig. 2 | Inter-individual variability in metabolite response to dietary intervention. A), Principal Component 
Analysis scores plot of 24hr urine collections, constructed from data for the extreme diets, Diet 1 (the most 
concordant with WHO dietary guidelines, dark green dots) and Diet 4 (the least concordant, red dots) on day 3, 
with the two intermediate diets (Diet 2, light green dots; Diet 3, orange dots) projected into the model.  B-D), urinary 
excretion of three exemplar individual metabolites (B, hippurate, C, 3-methyl histidine, D, carnitine) in samples 
obtained from participants on day 3 after consuming Diet 1 (green background) and Diet 4 (red background), 
stratified by sex. There are no differences between males and females in individual metabolite excretion (expressed 
in mmol per mol creatinine (Crn)) for any of the 4 diets. There is considerable inter -individual heterogeneity in 
metabolite excretion (Diets 1 and 4 for each person are connected by a line with each individual depicted by a 
different colour) despite rigorous standardisation of the dietary intervention study.  
 
Fig. 3 | Contribution of important 1H-NMR variables in the model. A, Average 600 MHz 1H-NMR spectrum with 
identified metabolites labelled. B, Manhattan plot showing -log10(q) × sign of regression coefficient (β) of the 
MCCV–PLS model for the 16,000 spectral variables. Green peaks represent the variables directly associated with 
Diet 1 and red peaks represent the variables with direct associations with Diet 4. A P-value was calculated for each 
variable by calculating a t-score using the mean regression coefficient of the 1,000 models and the variance on the 
basis of 25 bootstrap resamplings of the training data in each of 1000 models to estimate the variance of each 
coefficient (25,000 models). P-values were adjusted for multiple testing using the Storey-Tibshirani False Discovery 
Rate (FDR, q-value). The two horizontal lines indicate the cutoffs for the FDR on the log10 scale. Key: 1 – fatty 
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acids (C5-C10), 2 – 3-aminoisobutyrate, 3 – rhamnitol, 4- alanine, 5 – lysine, 6 – N-acetyl-S-(1Z)-propenyl-cysteine-
sulfoxide, 7 – N-acetylneuraminate, 8 – phenylacetylglutamine, 9 – O-acetylcarnitine, 10 – carnitine, 11 – 
dimethylamine, 12 – N-acetyl-S-methyl-cysteine-sulfoxide, 13 – S-methyl-cysteine-sulfoxide, 14 – creatine, 15 – 1-
methylhistine, 16 – 3-methylhistidine, 17 – trimethylamine-N-oxide, 18 – glucose, 19 – glycine, 20 – N-methyl-2-
pyridine-5-carboxamide, 21 – glycolate, 22 – 4-hydroxyhippurate, 23 – hippurate, 24 – tartrate, 25 – N-
methylnicotinate, 26 – N-methylnicotinamide, 27 – urea. 
 
Fig. 4 | Relationship between Dietary Metabotype Score and metabolic outcomes. A, 72hr trajectories of the 
Dietary Metabotype Score (DMS) derived from the MCCV-PLS predictions displayed for each participant (line 
colour relates to individual participants) for each diet. Each individual is ranked accordi ng to the DMS value from 
the model (created from Diets 1 and 4) and the ranking order is indicated by the colourbar on the right where green 
indicates highest rank and red indicates lowest after Diet 1. B-C, Comparison of the DMS before and after the 3-
day dietary interventions for Diet 1 (B) (most concordant with WHO guidelines) and Diet 4 (C) (least concordant). 
This demonstrates a reduction in metabolic variation after the dietary intervention compared to the home 
environment. There is no relationship between the order of DMS before and DMS ranking order after each diet 
(P=0.96 and P=0.99 for Diets 1 and 4, respectively). D, Relationship between the ranking order of the DMS and 
blood glucose concentration (see Methods) for each person after each test diet. The higher the DMS (indicated by 
the colour of the ranking order from panel A) of the participant, the lower the glucose concentration (area-under-
the-curve, AUC) measured in the participant after each test diet (median shown in black). E, Relationship between 
the DMS after following Diet 1 (green dots) and Diet 4 (red squares) for 3 days and the energy value (J/g of dried 
sample) of the urine with samples labelled according to participant ID. Higher energy excretion in the urine is 
associated with the DMS ranking order and highlights inter-individual variability. 
 
Fig. 5 | Urinary metabolic reaction networks built using the MetaboNetworks software. A, Urinary metabolic 
reaction networks map 27 visualizing connectivities between 32 urinary metabolites, the excretion of which 
significantly differed between Diet 1 (most concordant with WHO dietary guidelines) and Diet 4 (least concordant) 
for all 19 healthy participants. The node colour indicates whether the metabolite is excreted in higher concentrations 
in Diet 1 (green) or Diet 4 (red). Each edge (line between nodes) indicates a reaction (substrate-product 
relationship) and the white nodes (only named for nodes with three or more reactions) represent metabolites that 
connect the identified differential biomarkers of diet/dietary response in the human supra-organism metabolic 
reaction network (see Methods). The background shading indicates different class or type of metabolic pathways. 
B-C, The individualised differences in response to Diets 1 and 4 have been mapped onto the skeleton outline of 
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the urinary metabolic reaction network (panel A), where the size of coloured nodes is proportional to the fold-
change of that metabolite between Diets 1 and 4 for that person. The edge colours are related to the sum of fold-
changes of each pair of metabolites connected via their shortest path (see Methods). The metabolic entropy for 
each individual is calculated as the sum of the individual fold-changes 40. The more disordered or metabolically 
flexible (high entropy), a sub-network is, the stronger the associated edge weights (yellow-orange) in contrast to 
less perturbed pathways (magenta-blue edge weights). B, participant 6 (entropy=112.31); C, participant 16 
(entropy=74.46). This reflects the fact that diet has a stronger impact on participant 6 as evidenced by the greater 
magnitude of differences in the DMS for Diets 1 and 4 than the difference in response to these diets demonstrated 
by participant 6. Entropy is expressed in arbitrary units 
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The Extended Data contains 3 Figures and 1 Table. 
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The Supplementary Information contains 19 Figures and 4 Tables. 
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